Twist bioscience corp TWST.US 總覽分析

美股醫療保健
(Powered by Quartr Logo)

TWST 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

價值面評分中等,已經有部位可以持續持有,若想建立新部位可以等待價值評分轉變為4分以上、股利提升為2分以上

TWST 近期報酬表現

-0.52%

Twist bioscience corp

1.31%

同產業平均

0.58%

S&P500

與 TWST 同產業的標的表現

  • VCYT Veracyte inc
    價值 4 分趨勢 3 分波段 2 分籌碼 2 分股利 1 分
    查看更多

TWST 公司資訊

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.

TWST 股價